Source prnewswire
Artificial Intelligence (AI) in Genomics Market to Surpass US$ 19.72 Billion by 2030 – Coherent Market Insights
The city of Burlingame, California, is home to.The 11th of November. SAN FRANCISCO, March 22, 2023 /PRNewswire/ -- According to Coherent Market Insights, the global artificial intelligence (AI) in genomics market is estimated to reach an estimated USD 1 billion by 2023.It is expected that US$ 19 billion will be generated in 2023, up from US$ 15 billion in 2023.By 2030, the market is expected to reach 72 Billion and is projected to witness a compound annual growth rate (CAGR) of 50%.From 2023 to 2030, there will be an increase of 1%. As a result of the increasing biomedical and genomic datasets, the growing use of AI-based solutions, and the increasing focus on reducing turnaround times in drug discovery and diagnostics, the global artificial intelligence (AI) in genomics market is experiencing strong growth. As a result of the increasing biomedical and genomic datasets, the growing use of AI-based solutions, and the increasing focus on reducing turnaround times in drug discovery and diagnostics, the global artificial intelligence (AI) in genomics market is experiencing strong growth.Artificial Intelligence (AI) Market Trends and Analysis: An Overview of the Global Artificial Intelligence (AI) Market in Genomics: There is an increasing volume of genomic data available today, and advanced analytics are vital to deciphering complex genetic informatics in a fast and accurate way. Furthermore, artificial intelligence can accelerate drug discovery by identifying potential targets, predicting drug responses, and streamlining the development process, reducing costs and time. In the genomics market, the acceptance and demand for AI technologies is increasing as healthcare professionals and the general public become more aware of the benefits of AI in genomics.Here is a link where you can request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/6127/Takeaways from the market:It is anticipated that the global artificial intelligence (AI) in genomics market will reach US$ 19.72 Billion by 2030, with a CAGR of 50.1% from 2023 to 2030, primarily owing to advances in precision medicine, increased awareness and education among healthcare professionals, and the collaboration between AI companies and genomic research institutions during the forecast period.On the basis of Delivery Mode, the On-Premises segment of the global artificial intelligence (AI) in genomics market is expected to dominate in the projected period due to the flexibility that these solutions offer in allowing researchers to customize and scale AI applications to meet specific research requirements.The Genome Sequencing Segment, which is characterized by its functional capabilities, is expected to dominate the global artificial intelligence (AI) market in genomics over the next few years, as the integration of AI into genomics enables fast and accurate interpretation of genomic information, as well as disease diagnosis and treatment customization.Based on the application of translational precision medicine, it is likely that the global market will be dominated by this segment, as translational precision medicine enables better identification of diseases, more effective treatment strategies and allows the analysis of vast genomic data sets to be enhanced.Pharma companies are leveraging artificial intelligence to analyze a vast amount of genomics data and accelerating the process of drug discovery and development. The Pharma and Biotech companies segment is expected to hold a dominant position in the global market because pharma companies are leveraging artificial intelligence to analyze a vast amount of genomic data.The North American region is set to dominate the market throughout the forecast period owing to the growing number of projects in the U.S. to sequence the human genome, and multiple initiatives in the U.S. to sequence numerous patients with new diseases as well as the increasing technological advancements.Some of the leading players in the global market for artificial intelligence (AI) in genomics include Fabric Genomics, International Business Machines, MICROSOFT, NVIDIA, AI Therapeutics, Ares Genetics, Benevolent AI, Deep Genomics, DIPLOID, among others.Key Developments in the Global Artificial Intelligence (AI) in Genomics MarketIn December 2022, Intel Labs and the Perelman School of Medicine at the University of Pennsylvania undertook a collaborative study utilizing distributed machine learning and artificial intelligence techniques in order to assist international health organizations and research organizations in identifying malignant brain tumors in order to aid international health and research organizations,A partnership agreement between Hitachi and SPOHiA GENETICS was signed in March 2021. As a result of this partnership, pharmaceutical companies as well as healthcare practitioners have gained practical, clinical, and genetic insights which would further democratize the use of data driven precision medicine globally for the benefit of their patients.Read the complete market research report, "Artificial Intelligence (AI) in Genomics Market, By Delivery Mode, By Functionality, By Application, By End User, By Region and Segment Forecast 2023 - 2030", published by Coherent Market Insights.Market Segmentation of the Global Artificial Intelligence in Genomics Market:The premium research report can be purchased now at https://www.coherentmarketinsights.com/insight/buy-now/6127/Below you will find a list of trending reports related to this topic:Personalized Genomics Market, By Test Type (Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Others), By Technology (PCR-based Tests, Microarray-based Tests, Sequencing-based Tests, Others), By Application (Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition & Health Lifestyle, Others), By End User (Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)Personalized Genomics Market, By Test Type (Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Others), By Technology (PCR-based Tests, Microarray-based Tests, Sequencing-based Tests, Others), By Application (Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition & Health Lifestyle, Others), By End User (Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)A study of the Spatial Genomics Transcriptomics Market based on technology, application, end user, sample type, product type, end use industry, research type, workflow stage, collaboration type, and regions (North America, Latin America, Europe, Middle East & Africa, Asia Pacific) can help us better understand the market.Genomics and Proteomics Reagents, Research Kits, & Analytical Instrumentation Market, By Product Type (Instrumentation and Analytical Tools (Chromatography, Mass Spectrometry, Thermal Cyclers, Next Gen Sequencing), Reagents and Research Kits (Sample Prep Kits, Electrophoresis Kits, Purification Kits, BioChips)), By End User (Diagnostic Laboratories, Pharmaceutical and Biotechnology Organizations, Research Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027Genomics and Proteomics Reagents, Research Kits, & Analytical Instrumentation Market, By Product Type (Instrumentation and Analytical Tools (Chromatography, Mass Spectrometry, Thermal Cyclers, Next Gen Sequencing), Reagents and Research Kits (Sample Prep Kits, Electrophoresis Kits, Purification Kits, BioChips)), By End User (Diagnostic Laboratories, Pharmaceutical and Biotechnology Organizations, Research Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027Genomics Market by Product Type (Consumables, Software, and Others), by Technology (PCR, Microarray, Next Gene Sequencing, Nucleic Acid Extraction and Purification, and Others), by Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture & Animal Research, and Others), by End Users (Academic and Research Institute, Pharmaceutical & Biotechnology Companies, Hospital and Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028Genomics Market by Product Type (Consumables, Software, and Others), by Technology (PCR, Microarray, Next Gene Sequencing, Nucleic Acid Extraction and Purification, and Others), by Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture & Animal Research, and Others), by End Users (Academic and Research Institute, Pharmaceutical & Biotechnology Companies, Hospital and Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028Pharmacogenomics Market, by Technology (DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, and Other Technologies), by Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management and Others), by End User (Hospitals & Clinics, Research Institutions and Academic Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030Pharmacogenomics Market, by Technology (DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, and Other Technologies), by Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management and Others), by End User (Hospitals & Clinics, Research Institutions and Academic Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030Here's a little bit about us:As a global market intelligence and consulting firm, Coherent Market Insights offers syndicated research reports and customized research reports as well as consulting services to its clients. Our key strength lies in providing actionable insights and authentic reports across a wide range of industries, including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all of the other domains and sub-domains imaginable.. As a result of our highly reliable and accurate reports, we create value for our clients. Furthermore, we are committed to playing a leading role in offering insights in many sectors post-COVID-19 and continue to deliver measurable and sustainable results for our clients in these sectors as well Furthermore, we are committed to playing a leading role in offering insights in many sectors post-COVID-19 and continue to deliver measurable and sustainable results for our clients in these sectors as wellWe can be reached at Mr. ShahSenior Client Partner – Business DevelopmentCoherent Market InsightsPhone: US: +1-206-701-6702UK: +44-020-8133-4027Japan: +81-050-5539-1737India: +91-848-285-0837Email: [email protected] Website: https://www.coherentmarketinsights.comFollow Us: LinkedIn | TwitterHere is the logo for Coherent Market Insights: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpgCoherent Market Insights is the source for this informationAccording to Coherent Market Insights, the global ambulatory surgical center market is expected to reach a value of US$96.19 billion in 2023 and is expected to continue to grow...There is an estimation that the global Biostimulants market will be valued at US$ 2,938.7 million in 2022 based on the research conducted by Coherent Market Insights...Become a PRN subscriber and get PRN's top stories and curated news delivered directly to your inbox every week!
No Comments